CSF-Dynamics is a pioneering brand dedicated to the development of an innovative hydrocephalus shunt that addresses the major issues associated with current shunts on the market. This groundbreaking shunt is currently undergoing rigorous clinical testing, with an expected approval for clinical use by the end of 2027. CSF-Dynamics received a prestigious Horizon 2020 Phase 2 SME grant from the European Commission to support their First in Human trial, showcasing the recognition of their potential.

The brand aims to significantly reduce both revisions and complications by mimicking the physiological drainage of cerebrospinal fluid (CSF). This method of shunting to the intracranial sinus has shown tremendous promise, with results from a pilot study demonstrating a patent outlet that avoids overdrainage. The abstract of this study can be found in the Journal of Neurosurgery.

Based on these encouraging results, CSF-Dynamics plans to conduct a larger pivotal study in five countries, in collaboration with renowned medical institutions. This study will provide the necessary data for future regulatory approvals. Founded in 1996 by esteemed neurosurgeon Svend Erik Børgesen, CSF-Dynamics is driven by the vision of creating a radically improved hydrocephalus shunt that offers a long-lasting solution for patients.

Their innovative approach and dedication to advancing the field of neurosurgery make CSF-Dynamics a brand to watch. Contact CSF-Dynamics for more information on their groundbreaking technology and ongoing clinical trials